Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial

Author(s):
Blinman, P.; Mileshkin, L.; Khaw, P.; Goss, G.; Johnson, C.; Capp, A.; Brooks, S.; Wain, G.; Kolodziej, I.; Veillard, A.S.; O'Connell, R.; Creutzberg, C.L. (0000-0002-7008-4321); Stockler, M.R.; ANZGOG; PORTEC Grp
Published
2016
Publication type
Article / Letter to editor
endometrial cancerclinician preferencesadjuvant chemotherapydecision-makingpatient preferencesoutcomes research
Date issued
2016-11-08
Language
English
Is part of
British Journal of Cancer (2016), Vol. 115, no. 10, p. 1179-1185
hdl
1887/112973
doi
10.1038/bjc.2016.323